Exact Mass: 333.17221820000003

Exact Mass Matches: 333.17221820000003

Found 114 metabolites which its exact mass value is equals to given mass value 333.17221820000003, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Primidolol

Primidolol

C17H23N3O4 (333.16884780000004)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist Same as: D02389

   

2-(4-methoxyphenyl)-1-phenyl-1-(2-pyridinyl)-2-butanol

(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol

C22H23NO2 (333.1728698)


   

4-Hydroxyoctanedioylcarnitine

3-[(7-Carboxy-4-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H27NO7 (333.1787432)


4-hydroxyoctanedioylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxyoctanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-hydroxyoctanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-hydroxyoctanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyoctanedioylcarnitine

3-[(7-carboxy-3-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787432)


3-hydroxyoctanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyoctanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyoctanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyoctanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

3-{[6-(2-hydroxyethoxy)-6-oxohexanoyl]oxy}-4-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787432)


6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 6-(2-hydroxyethoxy)-6-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   
   
   
   
   
   

2-(4-HEXYLPHENYL)QUINOLINE-4-CARBOXYLICACID

2-(4-HEXYLPHENYL)QUINOLINE-4-CARBOXYLICACID

C22H23NO2 (333.1728698)


   

4-Cyanophenyl 4-trans-(4-ethylcyclohexyl)benzoate

4-Cyanophenyl 4-trans-(4-ethylcyclohexyl)benzoate

C22H23NO2 (333.1728698)


   

[6-(2-methylbutan-2-yl)pyridin-2-yl]-diphenylphosphane

[6-(2-methylbutan-2-yl)pyridin-2-yl]-diphenylphosphane

C22H24NP (333.16462740000003)


   

TERT-BUTYL 7-AMINO-4-OXO-3,4-DIHYDROSPIRO[BENZO[E][1,3]OXAZINE-2,4-PIPERIDINE]-1-CARBOXYLATE

TERT-BUTYL 7-AMINO-4-OXO-3,4-DIHYDROSPIRO[BENZO[E][1,3]OXAZINE-2,4-PIPERIDINE]-1-CARBOXYLATE

C17H23N3O4 (333.16884780000004)


   

Sibutramine hydrochloride monohydrate

Sibutramine hydrochloride monohydrate

C17H29Cl2NO (333.1626084)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

   

Enpromate

Enpromate

C22H23NO2 (333.1728698)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   
   

trans-4-Cyano[1,1-biphenyl]-4-yl 4-ethylcyclohexanecarboxylate

trans-4-Cyano[1,1-biphenyl]-4-yl 4-ethylcyclohexanecarboxylate

C22H23NO2 (333.1728698)


   

3-nitro-2,6-di(piperidin-1-yl)benzoic acid

3-nitro-2,6-di(piperidin-1-yl)benzoic acid

C17H23N3O4 (333.16884780000004)


   
   
   

3,4-Bis(benzyloxy)phenethylamine hydrochloride

3,4-Bis(benzyloxy)phenethylamine hydrochloride

C22H23NO2 (333.1728698)


   
   

Phe-Ala-Pro

Phe-Ala-Pro

C17H23N3O4 (333.16884780000004)


A tripeptide composed of L-phenylalanine, L-alanine and L-proline joined in sequence by peptide linkages.

   
   

(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol

(alphaS,betaS)-alpha-Ethyl-alpha-(4-methoxyphenyl)-beta-phenyl-2-pyridineethanol

C22H23NO2 (333.1728698)


   
   

4-Hydroxyoctanedioylcarnitine

4-Hydroxyoctanedioylcarnitine

C15H27NO7 (333.1787432)


   

3-Hydroxyoctanedioylcarnitine

3-Hydroxyoctanedioylcarnitine

C15H27NO7 (333.1787432)


   

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

C15H27NO7 (333.1787432)


   

3-(2-methoxyethyl)-2,4-dioxo-N-pentyl-1H-quinazoline-7-carboxamide

3-(2-methoxyethyl)-2,4-dioxo-N-pentyl-1H-quinazoline-7-carboxamide

C17H23N3O4 (333.16884780000004)


   

1,3-Dimethyl-5-[[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanyl)amino]methylidene]-1,3-diazinane-2,4,6-trione

1,3-Dimethyl-5-[[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanyl)amino]methylidene]-1,3-diazinane-2,4,6-trione

C17H23N3O4 (333.16884780000004)


   

Spectinomycin(1+)

Spectinomycin(1+)

C14H25N2O7+ (333.16616799999997)


A secondary ammonium ion derived from spectinomycin by protonation of the secondary amino group located between the two alcoholic hydroxy groups.

   

N-(6-acetyl-1,3-benzodioxol-5-yl)-2-(4-ethyl-1-piperazinyl)acetamide

N-(6-acetyl-1,3-benzodioxol-5-yl)-2-(4-ethyl-1-piperazinyl)acetamide

C17H23N3O4 (333.16884780000004)


   

N-[(1S)-2-hydroxy-1-phenylethyl]-N-(3-methylbut-2-enyl)-3-phenyl-2-propynamide

N-[(1S)-2-hydroxy-1-phenylethyl]-N-(3-methylbut-2-enyl)-3-phenyl-2-propynamide

C22H23NO2 (333.1728698)


   

4-Hydroxy-5-heptyl-6H-pyrido[3,2,1-jk]carbazole-6-one

4-Hydroxy-5-heptyl-6H-pyrido[3,2,1-jk]carbazole-6-one

C22H23NO2 (333.1728698)


   
   

4-(3-Acetyloxy-2-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Acetyloxy-2-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787432)


   

(1s,10s,13s)-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

(1s,10s,13s)-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

C17H23N3O4 (333.16884780000004)


   

(e,2e)-n-[(1e)-2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethenyl]-3-phenylprop-2-enimidic acid

(e,2e)-n-[(1e)-2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethenyl]-3-phenylprop-2-enimidic acid

C22H23NO2 (333.1728698)


   

n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethenyl)-3-phenylprop-2-enimidic acid

n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethenyl)-3-phenylprop-2-enimidic acid

C22H23NO2 (333.1728698)


   

(1r,10s,13s)-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

(1r,10s,13s)-13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

C17H23N3O4 (333.16884780000004)


   

13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

13-(hydroxymethyl)-10-isopropyl-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-2,4,6,8(15),11-pentaene-1,2,11-triol

C17H23N3O4 (333.16884780000004)


   

(3s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

(3s,11as,11bs)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H23N3O4 (333.16884780000004)


   

5-(3-amino-3-carboxypropyl)-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

5-(3-amino-3-carboxypropyl)-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H23N3O4 (333.16884780000004)


   

(3s,11ar,11br)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

(3s,11ar,11br)-5-[(3s)-3-amino-3-carboxypropyl]-1h,2h,3h,10h,11h,11ah,11bh-pyrido[2,1-f]1,6-naphthyridine-3-carboxylic acid

C17H23N3O4 (333.16884780000004)